Nowadays, the prevalence of sedentary lifestyles and high-caloric diets leads to an imbalance between energy intake and spending. Hence, in the last decades, researchers have observed a significant ...

A karate student thought she was just sore after an intense class - only to discover it was a deadly disease breaking down ...

The Thymidine Kinase 2 deficiency (TK2d) market is poised for substantial growth in the coming decade, fueled by increasing awareness of this rare genetic disorder and the development of promising ...

Group announced overnight that the National Institute for Health and Care Excellence has issued positive final guidance recommending Joenja for reimbursement and use within the National Health Service ...

Aclaris Therapeutics, Inc.’s ACRS share price has surged by 6.72%, which has investors questioning if this is right time to sell.

Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS Joenja® is the first and only medicine specifically for APDS to be reimbursed within the ...

Glycolytic capacity efforts are short, high-intensity efforts lasting 1–3 minutes where glycolysis is the primary energy ...

In regenerative science, B7-33's potential to influence fibroblast activity and collagen turnover suggests possible implications for tissue repair and wound healing. Given that fibrosis is often a ...

AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

Puma Biotechnology will issue its 1Q-2025 results after market close on May 8, 2025, and follow with a conference call at ...

Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment landscape for head and neck and lung cancer, and implications for specific drug ...